Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Innoviva (INVA) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Innoviva (INVA) over the last 17 years, with Q3 2025 value amounting to $476.5 million.

  • Innoviva's Cash & Equivalents rose 8283.12% to $476.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $476.5 million, marking a year-over-year increase of 8283.12%. This contributed to the annual value of $305.0 million for FY2024, which is 5759.35% up from last year.
  • Latest data reveals that Innoviva reported Cash & Equivalents of $476.5 million as of Q3 2025, which was up 8283.12% from $397.5 million recorded in Q2 2025.
  • Innoviva's Cash & Equivalents' 5-year high stood at $476.5 million during Q3 2025, with a 5-year trough of $43.3 million in Q2 2021.
  • Over the past 5 years, Innoviva's median Cash & Equivalents value was $217.0 million (recorded in 2024), while the average stood at $242.1 million.
  • Per our database at Business Quant, Innoviva's Cash & Equivalents crashed by 8952.79% in 2021 and then soared by 55544.9% in 2022.
  • Over the past 5 years, Innoviva's Cash & Equivalents (Quarter) stood at $201.5 million in 2021, then skyrocketed by 44.42% to $291.0 million in 2022, then tumbled by 33.51% to $193.5 million in 2023, then soared by 57.59% to $305.0 million in 2024, then skyrocketed by 56.25% to $476.5 million in 2025.
  • Its last three reported values are $476.5 million in Q3 2025, $397.5 million for Q2 2025, and $319.1 million during Q1 2025.